# Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug

> **NCT01630057** · PHASE4 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 200 (actual)

## Conditions studied

- Partial Seizures

## Interventions

- **DRUG:** Adjunctive Zonisamide
- **DRUG:** Replacement with Zonisamide

## Key facts

- **NCT ID:** NCT01630057
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-06
- **Final completion:** 2012-07
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2014-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01630057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01630057, "Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01630057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*